BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3084307)

  • 21. Occult hyperprolactinemia in infertile women.
    Asukai K; Uemura T; Minaguchi H
    Fertil Steril; 1993 Sep; 60(3):423-7. PubMed ID: 8375520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of occult hyperprolactinemia (OHP) on gonadotropin secretion system].
    Aisaka K; Yoshida K; Kayama F; Kimura Y; Tamechika S; Satoh K; Matsuoka R; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1994 Dec; 70(10):1101-14. PubMed ID: 7859890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient hyperprolactinemia in infertile women with luteal phase deficiency.
    Huang KE; Bonfiglio TA; Muechler EK
    Obstet Gynecol; 1991 Oct; 78(4):651-5. PubMed ID: 1923170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of bromocriptine on the pulsatile pattern and the circadian profile of gonadotropins and testosterone secretion in normal adult men].
    Aisaka K; Ogawa T; Mori H; Kigawa T
    Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):701-9. PubMed ID: 3932105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM; Nestor JJ; Vickery BH
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low serum levels of FSH, LH and prolactin in luteal phase inadequacy.
    Minakami H; Kimura K; Tamada T
    Endocrinol Jpn; 1985 Apr; 32(2):265-70. PubMed ID: 3930224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human menopausal gonadotropin/human chorionic gonadotropin-induced ovarian hyperstimulation with transient hyperprolactinemia: steroidogenesis enhanced during bromocriptine therapy in monkeys.
    Collins RL; Williams RF; Hodgen GD
    J Clin Endocrinol Metab; 1984 Oct; 59(4):727-33. PubMed ID: 6434577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics.
    Andersch B; Abrahamsson L; Wendestam C; Ohman R; Hahn L
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):657-64. PubMed ID: 575318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comprehensive approach to clinical background and effect of bromocriptine administration in patients with endocrinological polycystic ovarian disease].
    Aisaka K; Kaneda S; Tsuzuki H; Tawada T; Kokuho K; Toriya Y; Nojima M; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):101-12. PubMed ID: 2332079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial serum levels of gonadotropins, prolactin and sex steroids in the nonpregnant and pregnant chimpanzee.
    Reyes FI; Winter JS; Faiman C; Hobson WC
    Endocrinology; 1975 Jun; 96(6):1447-55. PubMed ID: 1126314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy.
    Smith MS; Freeman ME; Neill JD
    Endocrinology; 1975 Jan; 96(1):219-26. PubMed ID: 1167352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin levels and bromocriptine treatment of short luteal phase.
    Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
    Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulsatile secretion of ovarian steroids in the mid-luteal phase of the menstrual cycle].
    Kajimura H
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb; 66(2):134-44. PubMed ID: 2110081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal profile of the menstrual cycle in Chinese women after tubal sterilization.
    Wu E; Xiao B; Yan W; Li H; Wu B
    Contraception; 1992 Jun; 45(6):583-93. PubMed ID: 1617967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired steroidogenic function of corpora lutea from hyperprolactinemic baboons induced by sulpiride.
    Horie K; Ban C; Taii S; Mori T; Aso T
    Endocrinol Jpn; 1986 Apr; 33(2):211-4. PubMed ID: 3093203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of luteal phase inadequacy with bromocriptine.
    Saunders DM; Hunter JC; Haase HR; Wilson GR
    Obstet Gynecol; 1979 Mar; 53(3):287-9. PubMed ID: 424098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of drug-induced hyper- and hypoprolactinemia on human corpus luteum.
    Garcea N; Campo S; Siccardi P; Panetta V; Venneri M; Dargenio R
    Acta Eur Fertil; 1983; 14(1):35-40. PubMed ID: 6326451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.